Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alexey Kazachenok"'
Autor:
Maria Ilushina, Elvira Sultanova, Larisa Shelikhova, Svetlana Glushkova, Alexey Kazachenok, Elena Kurnikova, Kristina S. Antonova, Ruslan Nikolaev, Anna Bogoyavlenskaya, Galina Novichkova, Michael Maschan, Dmitriy Balashov, Elena Osipova, Tatiana Salimova, Julia Skvortsova, Yakov Muzalevsky, Alexey Maschan, Daria Shasheleva, Dmitry Pershin, Svetlana Radygina
Publikováno v:
Blood. 138:558-558
Introduction HSCT from matched family donors results in most favorable outcomes among children with severe aplastic anemia (SAA). Despite overall success, morbidity, associated with acute and chronic graft-versus-host disease (GVHD) is not completely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c348ce1412777a1187b687484e08a8d1
https://doi.org/10.1182/blood-2021-152769
https://doi.org/10.1182/blood-2021-152769
Autor:
Larisa Shelikhova, Olga Molostova, Arina Rakhteenko, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Yakov Muzalevsky, Alexey Kazachenok, Dmitry Pershin, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1736-1736
Introduction Autologous chimeric antigen receptor (CAR) T cells induce high rate of deep remissions among children with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R B-ALL). In a significant proportion of patients true cure is ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15b3bd8e387f5a4563dbb16dcab32fc3
https://doi.org/10.1182/blood-2021-153343
https://doi.org/10.1182/blood-2021-153343
Autor:
Olga Molostova, Larisa Shelikhova, Yakov Muzalevsky, Alexey Kazachenok, Rimma Khismatullina, Julia Abugova, Elena Kurnikova, Pavel Trakhtman, Dmitry Pershin, Viktoria Zubachenko, Maria Fadeeva, Alexander M Popov, Olga Illarionova, Natalia Miakova, Dmitry Litvinov, Galina Novichkova, Alexey Maschan, Michael Maschan
Publikováno v:
Blood. 138:1737-1737
Introduction CD19 CAR-T is a highly effective therapy among children with relapsed/refractory B-ALL. The optimal approach to delivery of this therapy and the best post-remission strategy remain to be established. We have tested in a prospective acade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f6f6923a4149e080e332b4dd4c5d62c
https://doi.org/10.1182/blood-2021-153414
https://doi.org/10.1182/blood-2021-153414
Autor:
Michael Maschan, Elena Kurnikova, Dmitry Balashov, Dmitry Pershin, Viktoria Zakharova, Alexey Kazachenok, Larisa Shelikhova, Kirill Voronin, Yakov Muzalevskii, Galina Novichkova, Maria Ilushina, Alexey Maschan, Zhanna Shekhovtsova
Publikováno v:
Pediatric transplantationREFERENCES. 24(1)
Both acute GVHD and chronic GVHD remain the leading cause of morbidity and death after allogeneic HSCT. We conducted a retrospective analysis comparing two GVHD-prophylaxis regimens: 35 patients received "Regimen 1" (horse ATG, tacrolimus, and methot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac630933c8b765a7f27ecd9c5131724
https://pubmed.ncbi.nlm.nih.gov/31680369
https://pubmed.ncbi.nlm.nih.gov/31680369
Autor:
Irina Shipitsina, Daria Kobyzeva, Maria Ilushina, Alexander Popov, Julia Abugova, Elena Kurnikova, Ekaterina Mikhailova, Yulia Olshanskaya, Larisa Shelikhova, Maria Fadeeva, Michael Maschan, Dmitriy Balashov, Alexey Maschan, Anna Bogoyavlenskaya, Zhanna Shekhovtsova, Alexey Nechesnyuk, Daria Shasheleva, Rimma Khismatullina, Alexey Kazachenok, Sergey Blagov, Natalia Miakova, Dmitriy Pershin, Yakov Muzalevsky, Galina Novichkova, Dmitry Litvinov
Publikováno v:
Blood. 134:4618-4618
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is indicated for patients with relapsed or refractory acute lymphoblastic leukemia. Patients with persistence of minimal residual disease (MRD) before HCT are at increased risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04adb8157fea9d37022860d90e3128e0
https://doi.org/10.1182/blood-2019-129792
https://doi.org/10.1182/blood-2019-129792
Autor:
Alexander Popov, Alexey Kazachenok, Dmitriy Pershin, Alexey Maschan, Daria Shasheleva, Rimma Khismatullina, Larisa Shelikhova, Elena Kurnikova, Evgeny V. Gluhanyuk, Yakov Muzalevsky, Galina Novichkova, Svetlana Kashpor, Irina Kalinina, Dmitriy Balashov, Michael Maschan
Publikováno v:
Blood. 134:150-150
Introduction The outcome HSCT in a cohort of children with chemorefractory acute leukemia (AL) is poor. The incidence of relapse exceeds 50% and survival varies from 10 to 40%. Additional attempts at remission induction with various combinations of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3f19b23c573516976a8ccb373418c91
https://doi.org/10.1182/blood-2019-129765
https://doi.org/10.1182/blood-2019-129765
Autor:
Alexey Moskalev, Ekaterina Plyusnina, Lyubov Shilova, Alexey Kazachenok, Mikhail V. Shaposhnikov, Alex Zhavoronkov
Publikováno v:
Cell Cycle
There is a relationship between various cellular stress factors and aging. In earlier studies, we demonstrated that overexpression of the D-GADD45 gene increases the life span of Drosophila melanogaster. In this study, we investigate the relationship
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12ea62ccd17ca9691ef107720ac7d21
http://europepmc.org/articles/PMC3524218
http://europepmc.org/articles/PMC3524218
Autor:
Elena Kurnikova, Irina Shipitsina, Maria Fadeeva, Anna Bogoyavlenskaya, Svetlana Kozlovskaya, Dmitriy Pershin, Michael Maschan, Dmitriy Balashov, Maria Ilushina, Alexey Nechesnyuk, Elena Gutovskaya, Yakov Muzalevsky, Yulia Olshanskaya, Dmitry Litvinov, Zhanna Shekhovtsova, Alexey Maschan, Alexey Kazachenok, Sergey Blagov, Galina Novichkova, Rimma Khismatullina, Natalia Miakova, Irina Kalinina, Daria Shasheleva, Larisa Shelikhova
Publikováno v:
Blood. 132:481-481
Introduction Relapse, graft-versus-host disease (GvHD) and associated non-relapse mortality are the main obstacles to successful hematopoietic stem cell transplantation in children with leukemia. αβ T cell depletion was developed to prevent GvHD an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb0bd408703a29661254db10fa8f8cce
https://doi.org/10.1182/blood-2018-99-116007
https://doi.org/10.1182/blood-2018-99-116007
Autor:
Boro Dropulic, Dmitry Litvinov, Yakov Muzalevsky, Galina Novichkova, Regina Alex, Alexander Karachunskiy, Mike Essl, Alexander Popov, Olga Molostova, Larisa Shelikhova, Rimas Orentas, Michael Maschan, Dmitriy Pershin, Dina Shneider, Elena Kurnikova, Alexey Maschan, Alexey Kazachenok, Natalia Miakova
Publikováno v:
Blood. 132:5202-5202
Introduction CD19 CAR-T cell products were recently approved as therapy for advanced B-cell lineage malignancies. The predominant manufacturing model for this type of therapy is a centralized industrial-type production process. An attractive model of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e34514800ed760ee45d200272646af3c
https://doi.org/10.1182/blood-2018-99-118282
https://doi.org/10.1182/blood-2018-99-118282
Autor:
Rimma Khismatullina, Larisa Shelikhova, Julia Starichkova, Alexey Kazachenok, Zhanna Shekhovtsova, Daria Shasheleva, Sergey Blagov, Elena Kurnikova, Dmitry Balashov, Alexey Maschan, Galina Novichkova, Maria Ilyushina, Dmitry Litvinov, Yuliya Skvortsova, Michael Maschan, Iakov Muzalevskyi
Publikováno v:
Blood. 128:3427-3427
Introduction: Graft-versus-host disease (GvHD) remains to be a factor associated with significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Bortezomib was shown in vitro to induce selective depletion of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e943cbf93bfa832baa739f5a99680152
https://doi.org/10.1182/blood.v128.22.3427.3427
https://doi.org/10.1182/blood.v128.22.3427.3427